TEAS RF New Application

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2018)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1478 (Rev 09/2006)

OMB No. 0651-0009 (Exp 02/28/2018)

Trademark/Service Mark Application, Principal Register

Serial Number: 87361159

Filing Date: 03/07/2017

To the Commissioner for Trademarks:

MARK: BLUEROCK (Standard Characters, see mark)
The literal element of the mark consists of BLUEROCK.
The mark consists of standard characters, without claim to any particular font style, size, or color.

The applicant, BlueRock Therapeutics LP, a limited partnership legally organized under the laws of Delaware, comprising of BlueRock Therapeutics GP LLC, having an address of
      c/o Versant Venture Management, LLC
      One Sansome, Suite 3630
      San Francisco, California 94104
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 001:  chemical and biological preparations for medical, industrial and scientific use, namely, body cells and cells of the immune system of mammals, including human cells; analytical kits consisting of chemical reagents for industrial and scientific use, for the purification, detection and immobilization of body cells and cells of the immune system of mammals, including human cells; diagnostic preparations except for medical purposes; combinations of cells and materials for biological use
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 005:  Cells for medical or clinical use; kits comprised of cells and pharmaceuticals for medical or clinical use; therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders; pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders; biological preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders; Gene therapy products, namely, therapeutics for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, renal, aural, respiratory, sensory-neural, urogenital, urological, hematologic, fungal and viral diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 040:  Manufacturing services for others in the field of pharmaceuticals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 042:  Scientific and industrial research in the field of biochemistry, diagnostics or pharmaceuticals; biochemical or pharmaceutical laboratory services, namely, cultivation and purification of cells, namely, of body cells and cells of the immune system of mammals including human cells; pharmaceutical research and development; medical research, namely, conducting clinical trials for others; providing a website featuring information about investigational medical devices, diagnostics and drugs; Research and development of human therapeutics using gene editing
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 044:  Providing medical information; providing a web site featuring medical information; providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


The applicant's current Attorney Information:
      Jessica L. Rothstein and Steven R. Argentieri, Stephen G. Charkoudian, Robert M. Crawford, Jr., Joel E. Lehrer, Jeffrey Rummler, Gessingga N. Storer, Bethany P. Withers, Adam M. Chud, Kevin V. Lam, Ira J. Levy, Achal Oza, Jessica Parise of Goodwin      620 Eighth Avenue
      New York, New York 10018
      United States
      212-813-8800(phone)
      212-355-3333(fax)
      NY-TM-Admin@goodwinprocter.com (authorized)
The attorney docket/reference number is 134089255183.

The applicant's current Correspondence Information:

Jessica L. Rothstein

GOODWIN

620 Eighth Avenue

New York, New York 10018

212-813-8800(phone)

212-355-3333(fax)

NY-TM-Admin@goodwinprocter.com;jrothstein@goodwinlaw.com; jnici@goodwinlaw.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $1375 has been submitted with the application, representing payment for 5 class(es).

Declaration

	If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application; and The facts set forth in the application are true. If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce on or in connection with the goods/services in the application; and The facts set forth in the application are true.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /jlr/   Date: 03/07/2017
Signatory's Name: Jessica L. Rothstein
Signatory's Position: Attorney of record, New York state bar member
Payment Sale Number: 87361159
Payment Accounting Date: 03/07/2017

Serial Number: 87361159
Internet Transmission Date: Tue Mar 07 10:39:27 EST 2017
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.X-2017030710392792
3575-87361159-580a23e9678152da6f3559e228
d6dad86e112d8ad63222a41d732942494dd432-C
C-9716-20170307102713523073